Inventor

ERHARDT PAUL W

US40 patents

⚠️ This page may combine multiple inventors who share the name “ERHARDT PAUL W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ERHARDT PAUL W

UNIV TOLEDO

Aralkyl ester soft drugs

Method and compositions for temporarily incapacitating subjects

Aralkyl ester soft drugs

Method of using α-substituted benzylamine chiral auxiliary synthetic reagents

Materials and methods useful to induce cancer cell death via methuosis or autophagy or a combination thereof

Proxisome proliferator activated receptor (PPAR) compounds and methods of using the same

Proxisome proliferator activated receptor (PPAR) compounds and methods of using the same

Analogs of proxisome proliferator activated receptor (PPAR) agonists and methods of using the same

Methods for producing two-substituted glycerols having various levels of protection

Materials and methods useful to induce vacuolization, cell death, or a combination thereof

Materials and methods useful to induce cancer cell death via methuosis or autophagy or a combination thereof

Method for the selective removal of acyl-functionality attached to the 2&#39;-hydroxy-group of paclitaxel-related derivatives

Materials and methods useful to induce cancer cell death via methuosis or autophagy or a combination thereof

Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs

Vacuole-inducing compounds, methods of making and using the same

Analogs of proxisome proliferator activated receptor (PPAR) agonists and methods of using the same

Analogs of proxisome proliferator activated receptor (PPAR) agonists and methods of using the same

Materials and Methods Useful to Induce Vacuolization, Cell Death, or a Combination Thereof

Inhibitors of ERCC1-XPF and methods of using the same

AMERICAN HOSPITAL SUPPLY CORP

Method for treatment or prophylaxis of cardiac disorders

Method for treatment or prophylaxis of cardiac disorders

Esters of thiadiazole oxypropanolaine derivatives and pharmaceutical uses

Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazole derivatives

Compounds and method for treatment or prophylaxis of cardiac disorders

Compounds for treatment or prophylaxis of cardiac disorders

Method for treatment or prophylaxis of cardiac disorders

Ethylenediamine derivatives of aryloxypropanolamine aryl esters having various medicinal properties

SCHERING AG

Imidazolylbenzoyl substituted heterocycles

Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones

Process for the preparation of imidazolonecarbonylarylimidazoles

Cardiotonic imidazolylphenylpyrrol-2-ones

BERLEX LAB

Potassium channel activators/openers

Prodrug derivatives of the cardiotonic agent 4-ethyl-1,3-dihydro-5-(4-(2-methyl-1H-imidazol-1-yl)benzoyl)-2H-imidazol-2-one, composition containing them, and method of using them to treat cardiac failure

Inhibitors of the conversion of big endothelin to endothelin

DU PONT

Esters of aryloxypropanolamine derivatives

Esters of aryloxypropanolamine derivatives

Esters of aryloxypropanolamine derivatives and medicinal uses

ERHARDT PAUL W

Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof

Methods for synthesizing glycinols, glyceollins I and II and isoflavenes and chromanes using a Wittig reaction, and compositions made therewith

MALTESE WILLIAM A

Materials and methods useful to induce cell death via methuosis

Method for the selective removal of acyl-functionality attached to the 2'-hydroxy-group of paclitaxel-related derivatives